U.S. FDA Accepts Regulatory Submission and Grants Priority Review for US WorldMeds ' Lofexidine

LOUISVILLE, Ky., Nov. 21, 2017 /PRNewswire/ -- US WorldMeds today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review of the New Drug Application (NDA) for lofexidine, an investigational product to...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news